XIAO Hongwei1,3, WANG Haoyu1, GE Zhenzhen1, ZHAO Jianqiang2, ZHOU Mingqiang1*, YUAN Weicheng1,2* |
1. National Engineering Research Center of Chiral Drugs, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu 610041, China; 2. Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China; 3. University of Chinese Academy of Sciences, Beijing 100049, China |